Researchers led by University of Illinois Urbana-Champaign chemical and biomolecular engineering professor Hyunjoon Kong and chemistry professor Hee Sun Han, and carried out by Ryan Miller, presently a post-doctoral fellow at Georgia Tech, have unveiled a breakthrough technology that might remodel the way in which scientists construct and examine lab-grown brain tissue fashions. The innovation, referred to as Cellular RedOx Spreading Shield (CROSS), delivers long-lasting antioxidant safety to stem cells, enabling the dependable manufacturing of high-quality extracellular vesicles (EVs) that strengthen neuron-glia networks. Jonghwi Lee, within the chemical engineering division at Chung-Ang University in South Korea, and Young Jun Kim on the Korean Institute of Science and Technology–Europe, collaborated on the challenge.
Why It Matters:
Stem cell-derived neuron-glia tissue fashions are superior alternate options to conventional research strategies, like ex vivo brain slices or animal testing, providing scalable programs to review brain improvement and illness, in addition to to additional biocomputing processes. Yet, present fashions usually endure from weak neural connections and immature cell networks. EVs, tiny particles produced by adipose-derived stem cells that carry organic molecules to speak with different cells may also help overcome these limitations, however producing them constantly at scale has been difficult, largely because of oxidative stress and the propagation of growing older cells inside bioreactors. Conventional antioxidants may also help, however they degrade rapidly, limiting their effectiveness in biomanufacturing processes.
CROSS makes use of a extremely environment friendly and scalable droplet microfluidic-based methodology for producing antioxidant crystal-loaded microgels which, when administered as a single dose, maintains antioxidant exercise for as much as seven days in stem cell cultures. Using N-acetylcysteine (NAC) as a mannequin antioxidant, researchers demonstrated that CROSS preserves stem cell well being, stabilizes EV manufacturing and prevents the unfold of oxidative harm. The ensuing EVs, enriched with neurogenic microRNA cargo, promoted structural and useful connectivity amongst neurons within the in vitro-assembled neural-glia tissue mannequin.
Key Findings:
- Efficient creation of liquid microdroplets containing NAC crystals with shear circulate and changing them into microgels creates CROSS with a diffusion barrier that prolongs antioxidant launch, sustaining efficacy for over every week.
- CROSS suppressed the unfold of cell growing older in a bioreactor, such that CROSS-treated stem cells produced EVs much like these from wholesome cells by no means uncovered to oxidative stress.
- When utilized to neuron-glia tissue programs, these EVs promoted electrophysiologically useful in vitro neural tissue meeting, an vital software for finding out neural improvement, homeostasis, ailments and biocomputing.
- Potential purposes embrace neural tissue regeneration and biohybrid applied sciences.
- CROSS affords an alternative choice to animal testing and supplies a sensible resolution for large-scale therapeutic EV manufacturing.
The Bottom Line:
“Our new microfluidic process provides a simple and versatile method for creating improved drug delivery carriers that can be tailored for various biological products. The small CROSS materials developed in this study could also help make the production of cell-based therapies more efficient, support the building of lab-grown tissues, and ultimately contribute to new treatment options for a range of diseases.” – Hyunjoon Kong
Notes:
To contact Hyunjoon Kong, e mail [email protected]
The examine, Shear-Induced CROSS (Cellular RedOx Spreading Shield) Assembly Sustains Neurotrophic Extracellular Vesicle Production for Functional Neural Networks, was printed in Advanced Functional Materials. DOI: 10.1002/adfm.202522252
This challenge was supported by the National Science Foundation, the National Institute of Health, a Chan Zuckerberg Biohub Chicago Investigator Grant, the National Aeronautics and Space Administration, the Bio-Cluster Industry Capacity Enhancement Project and the National Research Foundation of Korea.